Bank of America falls as rate volatility and sector-wide risk-off sentiment pressure bank shares

Bank of America Corporation (BAC) is down 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears primarily driven by a broader pullback in bank stocks tied to renewed interest-rate volatility after this week’s inflation data and heavy Treasury supply. BAC has also been trading with an added “overhang” from earlier-flagged 2026 profitability and regulatory uncertainties, making it more sensitive when investors rotate away from cyclical financials.

Details:

A key U.S. inflation report released Wednesday showed year-over-year CPI holding at 2.4%, reinforcing a “higher-for-longer” rate backdrop and keeping focus on interest-rate sensitivity across banks.

Thursday’s scheduled 30-year Treasury bond auction added to supply-related pressure in long-term rates, which can amplify daily swings in bank valuations and fixed-income exposures.

In its January 2026 materials tied to fourth-quarter results, the company discussed assumptions and outlook items (including net interest income and the forward rate curve), which investors have recently treated cautiously amid shifting rate expectations.

Separately, a 2026 stress-capital buffer notice kept attention on large-bank capital requirements, which can influence buyback capacity and sentiment even when the buffer is unchanged.

Sources:

U.S. Bureau of Labor Statistics, U.S. Department of the Treasury, Bank of America Investor Relations, Federal Reserve

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BAC Insider Trading Activity

$BAC insiders have traded $BAC stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $BAC stock by insiders over the last 6 months:

DEAN C ATHANASIA (Co-President) sold 136,558 shares for an estimated $6,856,167
JAMES P DEMARE (Co-President) sold 83,832 shares for an estimated $4,191,600
ALASTAIR M BORTHWICK (Executive Vice President & CFO) sold 68,000 shares for an estimated $3,416,320
SHERI B. BRONSTEIN (Chief People Officer) sold 60,000 shares for an estimated $2,994,600
THOMAS M SCRIVENER (Chief Operations Executive) sold 50,000 shares for an estimated $2,491,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BAC Hedge Fund Activity

We have seen 1,694 institutional investors add shares of $BAC stock to their portfolio, and 1,537 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 142,443,052 shares (-76.6%) from their portfolio in Q4 2025, for an estimated $7,834,367,860
BERKSHIRE HATHAWAY INC removed 50,774,078 shares (-8.9%) from their portfolio in Q4 2025, for an estimated $2,792,574,290
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 44,413,993 shares (+7091.3%) to their portfolio in Q4 2025, for an estimated $2,442,769,615
CAPITAL INTERNATIONAL INVESTORS added 42,862,620 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,357,444,100
CITIGROUP INC removed 29,298,493 shares (-54.9%) from their portfolio in Q4 2025, for an estimated $1,611,417,115
VANGUARD GROUP INC added 23,351,183 shares (+3.7%) to their portfolio in Q4 2025, for an estimated $1,284,315,065
CARDANO RISK MANAGEMENT B.V. added 22,621,546 shares (+914.5%) to their portfolio in Q4 2025, for an estimated $1,244,185,030

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BAC Congressional Stock Trading

Members of Congress have traded $BAC stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:

REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BAC Analyst Ratings

Wall Street analysts have issued reports on $BAC in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Keefe, Bruyette & Woods issued a "Outperform" rating on 01/15/2026
TD Cowen issued a "Buy" rating on 01/15/2026
Truist Securities issued a "Buy" rating on 01/15/2026
CICC issued a "Outperform" rating on 01/14/2026
Goldman Sachs issued a "Buy" rating on 01/06/2026
Barclays issued a "Overweight" rating on 01/05/2026
Oppenheimer issued a "Outperform" rating on 11/19/2025

To track analyst ratings and price targets for $BAC, check out Quiver Quantitative's $BAC forecast page.

$BAC Price Targets

Multiple analysts have issued price targets for $BAC recently. We have seen 13 analysts offer price targets for $BAC in the last 6 months, with a median target of $62.0.

Here are some recent targets:

Christopher McGratty from Keefe, Bruyette & Woods set a target price of $63.0 on 01/15/2026
Steven Alexopoulos from TD Cowen set a target price of $64.0 on 01/15/2026
John McDonald from Truist Securities set a target price of $60.0 on 01/15/2026
Scott Siefers from Piper Sandler set a target price of $57.0 on 01/15/2026
Betsy Graseck from Morgan Stanley set a target price of $64.0 on 01/15/2026
Glenn Schorr from Evercore ISI Group set a target price of $59.0 on 01/15/2026
An analyst from CICC set a target price of $62.0 on 01/14/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.